Best Angiotensin Converting Enzyme Inhibitor for diabetic nephropathies
7 Angiotensin Converting Enzyme Inhibitor drugs indicated for diabetic nephropathies, ranked by our independent rating. The current highest-rated is epaned. Compare them with all treatments for diabetic nephropathies or the full Angiotensin Converting Enzyme Inhibitor class. Not medical advice — always consult a professional.
Top angiotensin converting enzyme inhibitor for diabetic nephropathies: 1. Epaned · 2. Qbrelis · 3. Lotensin
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Epaned | 72/100 | Prescription | $0 | View → |
| 2 | Qbrelis | 72/100 | Prescription | $1 | View → |
| 3 | Lotensin |
Full ranking · 7 drugs
Frequently asked
- What is the best angiotensin converting enzyme inhibitor for diabetic nephropathies?
- By our independent rating, epaned currently ranks highest among Angiotensin Converting Enzyme Inhibitor drugs used for diabetic nephropathies. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which angiotensin converting enzyme inhibitor drugs treat diabetic nephropathies?
- pharmaranks lists 7 Angiotensin Converting Enzyme Inhibitor products indicated for diabetic nephropathies, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.